RepliCel Life Sciences Inc. (REPCF)

[Tailorgang44]

Correct, RCH-01 is in phase II trials, testing efficiency. This is being completed by Shiseido.

Lee Buckler said on twitter that Shiseido hasn't provided a deadline for trial results but they're expecting to hear results in September/October timeframe. If the results are positive and demonstrate the treatment is effective, Japan has a law that allows for Phase III trials to be skipped and Shiseido will take it straight to market launch. If this occurs and goes to market launch before the end of the year, Shiseido pays Replicel 30 Million dollars immediately as well as milestone and royalty payments as time goes on.

Huge potential if RCH-01 goes to market, not just for the stock but also for folks suffering from hair loss.